Saturday 31 October 2026
Export DOC’s income statement to Excel — free account
Healthpeak Properties, Inc.
DOC Real Estate Reit Healthcare Facilities
Healthpeak Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 4.52% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS grew 60.0%, free cash flow fell 30.5% and total debt rose 11.0%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for five.
19.03
0.09
+0.48%
Follow DOC
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
61.14 | 51.34 | 160.80 | 0.00 |
+8 more quarters Free account |
P/S ratio |
5.00 | 3.98 | 3.97 | 4.75 | |
P/FCF ratio |
0.00 | 255.36 | 32.98 | 26.12 | |
P/Operating CF |
40.88 | 43.78 | 38.06 | 42.25 | |
P/B ratio |
1.56 | 1.26 | 1.37 | 1.62 | |
Price to Tangible BV |
1.70 | 1.39 | 1.51 | 1.74 | |
EV/Sales |
7.82 | 7.16 | 7.26 | 7.95 | |
EV/EBITDA |
15.57 | 14.13 | 13.90 | 15.32 | |
EV/Operating CF |
18.75 | 16.68 | 16.38 | 17.95 | |
EV/FCF |
(1,193.91) | 460.09 | 60.42 | 43.74 | |
Quick Ratio |
2.64 | 2.02 | 0.86 | 0.32 | |
Current Ratio |
3.02 | 2.96 | 1.70 | 1.22 | |
Net Debt/EBITDA |
21.70 | 25.64 | 24.89 | 24.42 | |
Debt/Assets |
46.27% | 48.22% | 48.43% | 46.63% | |
Debt/Equity |
1.06 | 1.15 | 1.21 | 1.11 | |
Asset Turnover |
0.14 | 0.14 | 0.14 | 0.14 | |
Operating CF/Net income |
6.86 | 1.35 | 2.58 | (2.69) | |
Capex/Depreciation |
(0.83) | (1.81) | (1.50) | (0.85) | |
Interest Coverage |
1.35 | 1.06 | 1.73 | 1.68 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.92% | 3.27% | 3.28% | 2.82% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.04 | 0.03 | |
Share Based Compensation of Revenue |
0.62% | 1.24% | 0.56% | 0.57% | |
Graham Net Nets |
(0.69) | (0.93) | (0.98) | (0.78) | |
Graham Number |
10.40 | 9.67 | 5.13 | 0.00 | |
Earnings Yield |
1.64% | 1.95% | 0.62% | (0.26%) | |
Free Cash Flow Yield |
(0.13%) | 0.39% | 3.03% | 3.83% | |
Revenue per Share |
1.12 | 1.08 | 1.03 | 1.02 | |
Operating CF per Share |
0.52 | 0.38 | 0.42 | 0.45 | |
Capex per Share |
(0.31) | (0.69) | (0.51) | (0.29) | |
Free Cash Flow per Share |
0.21 | (0.31) | (0.08) | 0.16 | |
Cash per Share |
2.49 | 1.82 | 0.77 | 0.23 | |
Shareholders Equity per Share |
13.73 | 12.99 | 11.70 | 11.85 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
13.73 | 12.99 | 11.70 | 11.85 | |
Free Cash Flow |
146.19 | (218.74) | (58.42) | 111.65 | |
Working Capital |
1,373.53 | 1,317.78 | 503.54 | 167.85 | |
Capital Expenditures |
(214.91) | (479.62) | (352.51) | (203.31) | |
Net Current Asset Value |
(10,157.08) | (10,594.41) | (10,971.10) | (10,430.83) | |
EV/EBIT |
47.45 | 42.94 | 39.47 | 46.36 | |
Capex to Sales |
0.28 | 0.64 | 0.49 | 0.29 | |
Price to Operating Income |
30.35 | 23.83 | 21.54 | 27.69 | |
| Other line items | |||||
Average Receivables |
70.44 | 80.19 | 77.57 | 72.91 | |
Average Payables |
708.65 | 670.73 | 721.93 | 748.06 | |
Average Assets |
20,745.16 | 20,715.98 | 20,137.14 | 19,776.09 | |
Average Common Equity |
9,018.79 | 8,930.90 | 8,598.94 | 8,729.09 |
Columns are period end dates